Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Granulocytes and monocytes are crucial components of the innate immune system, originating from myeloid progenitors in the bone marrow. Granulocytes (neutrophils, eosinophils, and basophils) are characterized by cytoplasmic granules and multi-lobed nuclei, primarily involved in phagocytosis, enzyme release, and inflammation. Monocytes, larger cells with kidney-shaped nuclei, differentiate into macrophages and dendritic cells, performing phagocytosis and antigen presentation to activate adaptive immunity. Imbalances in granulocyte or monocyte numbers/function are implicated in infections, inflammation, autoimmune diseases, allergies, parasitic infections, and cancer, highlighting their importance in both acute defense and chronic disease pathogenesis.
Various, depending on the specific drug. Corticosteroids can suppress granulocyte and monocyte activity. Chemotherapy can reduce their numbers. Immunosuppressants can alter their function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granulocytes and Monocytes.